Cargando…

Precipitating Mechanisms of Falls in Preclinical Alzheimer’s Disease

BACKGROUND: Individuals with Alzheimer’s disease (AD) are more than twice as likely to incur a serious fall as the general population of older adults. Although AD is commonly associated with cognitive changes, impairments in other clinical measures such as strength or functional mobility (i.e., gait...

Descripción completa

Detalles Bibliográficos
Autores principales:	Keleman, Audrey A., Nicosia, Jessica, Bollinger, Rebecca M., Wisch, Julie K., Hassenstab, Jason, Morris, John C., Ances, Beau M., Balota, David A., Stark, Susan L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2023
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357117/ https://www.ncbi.nlm.nih.gov/pubmed/37483329 http://dx.doi.org/10.3233/ADR-230002

Ejemplares similares

Falls: a marker of preclinical Alzheimer disease: a cohort study protocol
por: Bollinger, Rebecca M, et al.
Publicado: (2021)

11 Clinical Manifestations of Neuroaxonal Injury
por: Keleman, Audrey A., et al.
Publicado: (2023)

254 Markers of Neurodegeneration Associate with Worse Performance of Complex Daily Tasks
por: Keleman, Audrey A., et al.
Publicado: (2022)

Is comprehensiveness critical? Comparing short and long format cognitive assessments in preclinical Alzheimer disease
por: Hassenstab, Jason, et al.
Publicado: (2021)

Current advances in digital cognitive assessment for preclinical Alzheimer's disease
por: Öhman, Fredrik, et al.
Publicado: (2021)

Using the A/T/N Framework to Examine Driving in Preclinical Alzheimer’s Disease
por: Roe, Catherine M., et al.
Publicado: (2018)

Naturalistic driving measures of route selection associate with resting state networks in older adults
por: Wisch, Julie K., et al.
Publicado: (2022)

Vascular endothelial‐cadherin as a marker of endothelial injury in preclinical Alzheimer disease
por: Tarawneh, Rawan, et al.
Publicado: (2022)

Quantification of white matter cellularity and damage in preclinical and early symptomatic Alzheimer's disease
por: Wang, Qing, et al.
Publicado: (2019)

Tau and Aβ imaging, CSF measures, and cognition in Alzheimer's disease
por: Brier, Matthew R., et al.
Publicado: (2016)

Diversity in fall characteristics hampers effective prevention: the precipitants, the environment, the fall and the injury
por: Sanders, K. M., et al.
Publicado: (2017)

A practitioner's guide to geospatial analysis in a neuroimaging context
por: Wisch, Julie K., et al.
Publicado: (2023)

Predicting continuous amyloid PET values with CSF and plasma Aβ42/Aβ40
por: Wisch, Julie K., et al.
Publicado: (2023)

Multimodal brain age estimates relate to Alzheimer disease biomarkers and cognition in early stages: a cross-sectional observational study
por: Millar, Peter R, et al.
Publicado: (2023)

Relationships between big‐five personality factors and Alzheimer's disease pathology in autosomal dominant Alzheimer's disease
por: Aschenbrenner, Andrew J., et al.
Publicado: (2020)

Down syndrome and Alzheimer's disease: A scoping review of functional performance and fall risk
por: Washington, Selena E., et al.
Publicado: (2023)

Preclinical Alzheimer's disease and longitudinal driving decline
por: Roe, Catherine M., et al.
Publicado: (2016)

Identifying individuals with Alzheimer's disease‐like brains based on structural imaging in the Human Connectome Project Aging cohort
por: Li, Binyin, et al.
Publicado: (2021)

Precipitous Fall in Common Respiratory Viral Infections During COVID-19
por: Parry, Michael F, et al.
Publicado: (2020)

A Mixed Methods Study Exploring Older Womens' Attitudes Toward Osteoporosis Medications: Adapting a Health Communication Framework
por: Fuzzell, Lindsay N., et al.
Publicado: (2020)

Increasing hub disruption parallels dementia severity in autosomal dominant Alzheimer disease
por: Tu, Jiaxin Cindy, et al.
Publicado: (2023)

GPS driving: a digital biomarker for preclinical Alzheimer disease
por: Bayat, Sayeh, et al.
Publicado: (2021)

Moving Toward Disentangling Heterogeneity in Central Nervous System Complications in People With Human Immunodeficiency Virus
por: Rubin, Leah H, et al.
Publicado: (2023)

Plasma phosphorylated tau 217 in preclinical Alzheimer’s disease
por: Jonaitis, Erin M, et al.
Publicado: (2023)

A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium
por: Gross, Alden L., et al.
Publicado: (2017)

Early affective changes and increased connectivity in preclinical Alzheimer's disease
por: Fredericks, Carolyn A., et al.
Publicado: (2018)

Monthly At-Home Computerized Cognitive Testing to Detect Diminished Practice Effects in Preclinical Alzheimer's Disease
por: Jutten, Roos J., et al.
Publicado: (2022)

Nivolumab‐induced fulminant type 1 diabetes with precipitous fall in C‐peptide level
por: Miyauchi, Masaaki, et al.
Publicado: (2019)

Hierarchical Particle Approach for Co-Precipitated Amorphous Solid Dispersions for Use in Preclinical In Vivo Studies
por: Schenck, Luke, et al.
Publicado: (2021)

Study partners should be required in preclinical Alzheimer’s disease trials
por: Grill, Joshua D., et al.
Publicado: (2017)

Neuroinflammation and amyloid deposition in the progression of mixed Alzheimer and vascular dementia
por: Ying, Chunwei, et al.
Publicado: (2023)

Onset of Preclinical Alzheimer Disease in Monozygotic Twins
por: Konijnenberg, Elles, et al.
Publicado: (2021)

Ante‐ and postmortem tau in autosomal dominant and late‐onset Alzheimer’s disease
por: Chen, Charles D., et al.
Publicado: (2020)

Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease
por: Samaroo, Aubryn, et al.
Publicado: (2021)

How Do Community-Dwelling Persons with Alzheimer Disease Fall? Falls in the FINALEX Study
por: Perttila, Niko M., et al.
Publicado: (2017)

Bridging the Technological Divide: Stigmas and Challenges With Technology in Digital Brain Health Studies of Older Adults
por: Nicosia, Jessica, et al.
Publicado: (2022)

CSF Tau phosphorylation at Thr205 is associated with loss of white matter integrity in autosomal dominant Alzheimer disease
por: Strain, Jeremy F., et al.
Publicado: (2022)

Unsupervised mobile cognitive testing for use in preclinical Alzheimer's disease
por: Papp, Kathryn V., et al.
Publicado: (2021)

Virtual disclosure of preclinical Alzheimer's biomarkers: Preliminary experiences
por: Erickson, Claire M., et al.
Publicado: (2021)

“Text It” program to track falls in patients with Alzheimer's disease and dementia
por: Kamil, Rebecca J., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_56g6gd3poo665k4mc43e2u8oag